Research Paper Volume 14, Issue 18 pp 7390—7407
Comprehensive analysis of the differential expression and prognostic value of COL1A2 in colon adenocarcinoma
Figure 4. The COL1A2 promoter methylation level in colon adenocarcinoma based on various clinicopathological parameters. (A) Age. (B) Gender. (C) Weight. Normal weight: 18.5 ≤ BMI < 25; Overweight: 25 ≤ BMI < 30; Obese: 30 ≤ BMI<40; Extreme obese: BMI > 40. Abbreviation: BMI: body-mass-index. (D) Histological subtypes. (E) Cancer stage. (F) Nodal metastasis status. #P < 0.05; ##P < 0.01; ###P < 0.001.